WallStSmart

Dolby Laboratories (DLB)vsGlobal Payments Inc (GPN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Global Payments Inc generates 654% more annual revenue ($10.21B vs $1.35B). DLB leads profitability with a 16.7% profit margin vs -9.2%. GPN appears more attractively valued with a PEG of 0.27. GPN earns a higher WallStSmart Score of 59/100 (C).

DLB

Hold

44

out of 100

Grade: D

Growth: 2.7Profit: 6.5Value: 6.7Quality: 8.5
Piotroski: 3/9Altman Z: 4.85

GPN

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 4.0Value: 8.0Quality: 4.5
Piotroski: 4/9Altman Z: 1.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DLBUndervalued (+35.1%)

Margin of Safety

+35.1%

Fair Value

$106.46

Current Price

$64.48

$41.98 discount

UndervaluedFair: $106.46Overvalued
GPNUndervalued (+49.5%)

Margin of Safety

+49.5%

Fair Value

$142.91

Current Price

$88.29

$54.62 discount

UndervaluedFair: $142.91Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DLB3 strengths · Avg: 9.3/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.8510/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

GPN3 strengths · Avg: 10.0/10
PEG RatioValuation
0.2710/10

Growing faster than its price suggests

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
68.6%10/10

Revenue surging 68.6% year-over-year

Areas to Watch

DLB4 concerns · Avg: 3.3/10
PEG RatioValuation
2.084/10

Expensive relative to growth rate

P/E RatioValuation
26.5x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-3.3%2/10

Revenue declined 3.3%

GPN4 concerns · Avg: 2.0/10
P/E RatioValuation
44.0x2/10

Premium valuation, high expectations priced in

Return on EquityProfitability
-4.1%2/10

ROE of -4.1% — below average capital efficiency

EPS GrowthGrowth
-95.2%2/10

Earnings declined 95.2%

Altman Z-ScoreHealth
1.022/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DLB

The strongest argument for DLB centers on Debt/Equity, Altman Z-Score, Price/Book. Profitability is solid with margins at 16.7% and operating margin at 12.6%.

Bull Case : GPN

The strongest argument for GPN centers on PEG Ratio, Price/Book, Revenue Growth. Revenue growth of 68.6% demonstrates continued momentum. PEG of 0.27 suggests the stock is reasonably priced for its growth.

Bear Case : DLB

The primary concerns for DLB are PEG Ratio, P/E Ratio, Piotroski F-Score.

Bear Case : GPN

The primary concerns for GPN are P/E Ratio, Return on Equity, EPS Growth. A P/E of 44.0x leaves little room for execution misses.

Key Dynamics to Monitor

DLB profiles as a declining stock while GPN is a hypergrowth play — different risk/reward profiles.

DLB carries more volatility with a beta of 0.80 — expect wider price swings.

GPN is growing revenue faster at 68.6% — sustainability is the question.

GPN generates stronger free cash flow (427M), providing more financial flexibility.

Bottom Line

GPN scores higher overall (59/100 vs 44/100) and 68.6% revenue growth. DLB offers better value entry with a 35.1% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dolby Laboratories

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.

Global Payments Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Global Payments Inc. is an American company providing financial technology services globally headquartered in Atlanta, Georgia.

Visit Website →

Want to dig deeper into these stocks?